These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12416082)
1. [COX-2 inhibitors--can we rely on the articles?]. Lindberg M Ugeskr Laeger; 2002 Oct; 164(42):4945-6; author reply 4946. PubMed ID: 12416082 [No Abstract] [Full Text] [Related]
2. [A new interesting study on coxib]. Carlqvist M; Ohlén K Lakartidningen; 2003 Apr; 100(14):1261. PubMed ID: 12756658 [No Abstract] [Full Text] [Related]
3. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results]. Andersson T; Frösing R Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957 [No Abstract] [Full Text] [Related]
4. [Celecoxib and the CLASS trial]. Englev E; Christensen KB Ugeskr Laeger; 2002 Oct; 164(41):4825-6. PubMed ID: 12407895 [No Abstract] [Full Text] [Related]
5. [Analgesic in osteoporosis. Why so conservative with dosage?]. Pfeifer M MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349 [No Abstract] [Full Text] [Related]
6. [...bad example of a miserable "research on order"]. Moan A; Skattebøl A Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2220. PubMed ID: 12426904 [No Abstract] [Full Text] [Related]
7. [Celebra and the CLASS trial--a scandal!]. Lindberg M Ugeskr Laeger; 2002 Nov; 164(46):5407-8; author reply 5408. PubMed ID: 12469395 [No Abstract] [Full Text] [Related]
8. [Celecoxib and the CLASS study--worse and worse...]. Slørdal L Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2219. PubMed ID: 12426903 [No Abstract] [Full Text] [Related]
9. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model. Umar A; Boisseau M; Yusup A; Upur H; Bégaud B; Moore N Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377 [TBL] [Abstract][Full Text] [Related]
10. [Osteoarthritis and COX-2 inhibitors]. Lindberg M Ugeskr Laeger; 2002 Aug; 164(33):3874. PubMed ID: 12216162 [No Abstract] [Full Text] [Related]
11. [COX-2 inhibitors--actually, why to use them?]. Lindberg M Lakartidningen; 2002 Nov; 99(48):4904-6. PubMed ID: 12523080 [No Abstract] [Full Text] [Related]
12. Treating the symptoms of osteoarthritis-oral treatments. McMahon K; Nelson M; Jones G Aust Fam Physician; 2008 Mar; 37(3):133-5. PubMed ID: 18345361 [TBL] [Abstract][Full Text] [Related]
13. [Are COX-2 inhibitors a risk factor for cardiovascular disease?]. John S; Schmieder RE Dtsch Med Wochenschr; 2002 Jan; 127(4):156-9. PubMed ID: 11807660 [No Abstract] [Full Text] [Related]
14. Gastrointestinal outcomes: evidence for risk reduction in patients using coxibs. Scheiman JM Am J Manag Care; 2002 Nov; 8(17 Suppl):S518-28. PubMed ID: 12458821 [TBL] [Abstract][Full Text] [Related]
16. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of osteoarthritis with COX-2 inhibitors: good for the stomach, but bad for the patient?]. Andersen SE Ugeskr Laeger; 2002 Aug; 164(33):3874-5. PubMed ID: 12216163 [No Abstract] [Full Text] [Related]
18. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid]. MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082 [No Abstract] [Full Text] [Related]
19. [COX-2 inhibitors and data interpretation]. Raeder J Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2672; author reply 2672. PubMed ID: 16215622 [No Abstract] [Full Text] [Related]